US-based CBD producer Folium Biosciences is looking to tap Asian markets by creating a dedicated stalk extraction line which it believes will meet the strict regulatory requirements of Japan and South Korea
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields